Crossmark

Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS

Crossref DOI link: https://doi.org/10.1039/C8MT00012C

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Klose, Matthias H. M. https://orcid.org/0000-0002-7601-8333
Theiner, Sarah https://orcid.org/0000-0001-5301-0139
Kornauth, Christoph

Meier-Menches, Samuel M. https://orcid.org/0000-0002-8930-4574
Heffeter, Petra https://orcid.org/0000-0001-6401-8646
Berger, Walter https://orcid.org/0000-0003-0014-1658
Koellensperger, Gunda https://orcid.org/0000-0002-1460-4919
Keppler, Bernhard K. https://orcid.org/0000-0003-0877-1822
License Information

Accepted Manuscript valid from 2019-02-28
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Matthias H. M. Klose (ORCID)

: Sarah Theiner (ORCID)

: Samuel M. Meier-Menches (ORCID)

: Petra Heffeter (ORCID)

: Walter Berger (ORCID)

: Gunda Koellensperger (ORCID)

: Bernhard K. Keppler (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 8 January 2018; Accepted 16 February 2018; Accepted Manuscript published 28 February 2018; Advance Article published 7 March 2018; Version of Record published 21 March 2018